The global pressure ulcer treatment market size was estimated to be USD 9.30 billion in 2023 and is expected to reach at USD 19.14 billion by 2034 with a CAGR of 6.78% during the forecast period 2024-2034. Rising aging population which is more susceptible to pressure ulcers (bedsores), increased funding for research & development by major companies, an emphasis on the development of innovative wound care products, an upsurge in the introduction of advanced technological devices, rise in the awareness regarding the availability of treatments for pressure ulcers, growing advancement of wound care therapy, and surge in the introduction of novel wound dressing products are a few of the main elements driving the market's expansion.
Surge in the introduction of novel wound dressing products is predicted to boost the market growth during the forecast period. Injuries to the skin and tissues that are mainly brought on by continuous pressure on the skin are called pressure ulcers, often known as bedsores or pressure sores. The severity of pressure ulcers can vary, ranging from discolored skin patches to open lesions that reveal the underlying muscle or bone. As a result, because patients are enduring extended hospital stays and developing pressure ulcers, leaders in the field are concentrating on developing new therapeutic alternatives. For instance, in June 2023, Epicite Balance wound dressing is introduced to the German market by JeNaCell, an Evonik firm.
By type, stage 1 was the highest revenue-grossing segment in the global Pressure Ulcer Treatment Market in 2023 owing to the rise in the number of stage 1 injuries, which also results in an increase in the use of pressure ulcer medication and the launch of new products. For instance, in January 2023, Invacare has introduced the Dacapo Excel, a new mattress designed to redistribute pressure effectively and manage microclimate, catering to specific needs in pressure care. Additionally, stage 2 is predicted to grow at the fastest CAGR during the forecast period owing to the rise in the number of individuals suffering from stage 2 pressure ulcers and the rising use of different treatments for this ulcer.
By treatment, wound care dressings was the highest revenue-grossing segment in the global Pressure Ulcer Treatment Market in 2023 owing to the growing technological developments in foam dressing and increase in the introduction of new foam dressing. Additionally, wound care devices is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of cutting-edge treatment alternatives and an increase in the use of sophisticated wound dressings to treat pressure ulcer wounds. For instance, in January 2022, Smith+Nephew has introduced additional approved applications for its PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy (sNPWT) Systems. The U.S. Food and Drug Administration (FDA) has granted clearance for the utilization of these systems on closed surgical incisions.
By end-user, hospitals was the highest revenue-grossing segment in the global Pressure Ulcer Treatment Market in 2023 owing to the hospitals' growing preference for sophisticated wound care solutions, the increasing incidence of pressure ulcers in inpatient settings, their increased investment in these products to shorten hospital stays, and rising introduction of advanced products. For instance, in January 2024, In the US, Coloplast introduces Biatain Silicone Fit to avoid pressure injuries and treat wounds. Additionally, homecare is predicted to grow at the fastest CAGR during the forecast period owing to the rise in the elderly population, the accessibility and quality of homecare protocols for pressure ulcer prevention, and the trend away from hospital visits toward self-care at home for pressure ulcer treatment.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising geriatric population, increasing cases of pressure ulcers, and surge in demand for dressings, devices, & sealants, and growing launch of new products. For instance, in January 2023, Convatec has declared the introduction of ConvaFoam in the United States, a series of sophisticated foam dressings created to meet the requirements of both healthcare providers and their patients. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increase in patient awareness toward advanced wound care products, surge in demand for advanced wound care products, rise in the adoption of advanced technologies in wound care therapy, and growing launch of innovative products. For instance, in August 2022, 3M has released new enhancements for its wound care products. Healthcare providers should find it easier to provide care with the new 3M Veraflow Cleans Choice Complete dressing kit. A new software update for the 3M VAC Ultra treatment device was also released by the business.
Surge in the introduction of novel wound dressing products is predicted to boost the market growth during the forecast period. Injuries to the skin and tissues that are mainly brought on by continuous pressure on the skin are called pressure ulcers, often known as bedsores or pressure sores. The severity of pressure ulcers can vary, ranging from discolored skin patches to open lesions that reveal the underlying muscle or bone. As a result, because patients are enduring extended hospital stays and developing pressure ulcers, leaders in the field are concentrating on developing new therapeutic alternatives. For instance, in June 2023, Epicite Balance wound dressing is introduced to the German market by JeNaCell, an Evonik firm.
By type, stage 1 was the highest revenue-grossing segment in the global Pressure Ulcer Treatment Market in 2023 owing to the rise in the number of stage 1 injuries, which also results in an increase in the use of pressure ulcer medication and the launch of new products. For instance, in January 2023, Invacare has introduced the Dacapo Excel, a new mattress designed to redistribute pressure effectively and manage microclimate, catering to specific needs in pressure care. Additionally, stage 2 is predicted to grow at the fastest CAGR during the forecast period owing to the rise in the number of individuals suffering from stage 2 pressure ulcers and the rising use of different treatments for this ulcer.
By treatment, wound care dressings was the highest revenue-grossing segment in the global Pressure Ulcer Treatment Market in 2023 owing to the growing technological developments in foam dressing and increase in the introduction of new foam dressing. Additionally, wound care devices is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of cutting-edge treatment alternatives and an increase in the use of sophisticated wound dressings to treat pressure ulcer wounds. For instance, in January 2022, Smith+Nephew has introduced additional approved applications for its PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy (sNPWT) Systems. The U.S. Food and Drug Administration (FDA) has granted clearance for the utilization of these systems on closed surgical incisions.
By end-user, hospitals was the highest revenue-grossing segment in the global Pressure Ulcer Treatment Market in 2023 owing to the hospitals' growing preference for sophisticated wound care solutions, the increasing incidence of pressure ulcers in inpatient settings, their increased investment in these products to shorten hospital stays, and rising introduction of advanced products. For instance, in January 2024, In the US, Coloplast introduces Biatain Silicone Fit to avoid pressure injuries and treat wounds. Additionally, homecare is predicted to grow at the fastest CAGR during the forecast period owing to the rise in the elderly population, the accessibility and quality of homecare protocols for pressure ulcer prevention, and the trend away from hospital visits toward self-care at home for pressure ulcer treatment.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising geriatric population, increasing cases of pressure ulcers, and surge in demand for dressings, devices, & sealants, and growing launch of new products. For instance, in January 2023, Convatec has declared the introduction of ConvaFoam in the United States, a series of sophisticated foam dressings created to meet the requirements of both healthcare providers and their patients. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increase in patient awareness toward advanced wound care products, surge in demand for advanced wound care products, rise in the adoption of advanced technologies in wound care therapy, and growing launch of innovative products. For instance, in August 2022, 3M has released new enhancements for its wound care products. Healthcare providers should find it easier to provide care with the new 3M Veraflow Cleans Choice Complete dressing kit. A new software update for the 3M VAC Ultra treatment device was also released by the business.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
Study Coverage
- Market Forecast by Type, Material, Product, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Pressure Ulcer Treatment Market Report 2023 - 2034
Pressure Ulcer Treatment Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Stage 1
- Stage 2
- Stage 3
- Stage 4
- Deep Tissue Injury
Pressure Ulcer Treatment Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)
- Active Wound Care Therapies
- Growth Factors
- Skin Substitutes
- Wound Care Devices
- Pressure Relieving Devices
- Hyperbaric Oxygen Equipment
- Negative Pressure Wound Therapy
- Others
- Wound Care Dressings
- Foams Dressings
- Film Dressings
- Collagen Dressings
- Hydrogel Dressings
- Others
Pressure Ulcer Treatment Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospital
- Homecare
- Others
Pressure Ulcer Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Pressure Ulcer Treatment Market: Type Estimates & Trend Analysis
8. Pressure Ulcer Treatment Market: Treatment Estimates & Trend Analysis
9. Pressure Ulcer Treatment Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Pressure Ulcer Treatment Market
12. Europe Pressure Ulcer Treatment Market
13. Asia Pacific Pressure Ulcer Treatment Market
14. Latin America Pressure Ulcer Treatment Market
15. MEA Pressure Ulcer Treatment Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Cardinal Health
- Smith & Nephew PLC
- 3M Company
- B. Braun Melsungen AG
- ConvaTec Group PLC
- Baxter International Inc. (Hill-Rom Holdings Inc.)
- Coloplast Group
- Essity Aktiebolag
- Molnlycke Health Care AB
- Integra LifeSciences Holding Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 9.3 Billion |
| Forecasted Market Value ( USD | $ 19.14 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
